Article: For The Record.(Briefs)(Baxter AG recalled blood thinner Heparin)(Abbott and Co. ended its partnership with Takeda Pharmaceutical Company Ltd.)(Patrick Ryan retires from Heidrick & Struggles International Inc.)

Three media moguls are vying to buy New York's Newsday from debt-laden Tribune, the New York Times reported, citing people involved in the sale process. The newspaper identified the bidders as Rupert Murdoch, chairman of News Corp., Mortimer Zuckerman, and James Dolan, whose family controls Cablevision Systems. An analyst quoted by Crain's New York Business estimated Newsday could be worth $350 million to $400 million.

The FDA identified the contaminant found in some batches of Baxter's recalled blood thinner Heparin as oversulfated chondroitin sulfate. Investigators aim to learn if the substance caused as many as 19 deaths. Baxter insists the contaminant further ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!